Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Addiction. 2013 Mar 13;108(6):1095–1106. doi: 10.1111/add.12114

Table 5.

Time Participants Spent Preparing Tablets for Intranasal Abuse, and Self-Reported Maximum Time Participants Would Spend Preparing Tablets for Intranasal Abuse

Actual Time Spent Preparing Tablets (minutes)1 Maximum Time Would Spend Preparing Tablets (minutes)2
M SD Range M SD Range
OXY40 2.9** 1.9 0.7 to 8.8 4.8* 4.8 1.0 to 15.3
TAP50 5.9** 4.9 0.9 to 20.9 10.8* 12.7 0.0 to 28.7
TAP250 7.1** 4.6 0.9 to 16.2 11.6** 12.5 0.0 to 48.9

M=Mean, SD=Standard deviation

**

p<.01;

*

p<.05, TAP50 vs. OXY40, and TAP250 vs. OXY40

1

F(2, 24)=9.55, p=.0003;

2

F(2, 24)= 6.60, p=.003.